Page 1 Corporate Governance Statement 30 June 2026 This Corporate Governance Statement of Arovella Therapeutics Limited (“Arovella” or “the Company”) is prepared in accordance with ASX Listing Rule 4.10.3. It is for the financial year ended 30 June 2026 and is accurate and...
Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Appendix 4G
- Appendix 4E and Annual Report
- Notification regarding unquoted securities - ALA
- Investor Webinar Presentation
- Investor Webinar Registration
Later from Arovella Therapeutics
- Clinical manufacturing batch released, first site activated
- Notification of 2026 AGM Date
- 2026 ESG Report
- The path to first patient dosing
- Notice of Annual General Meeting/Proxy Form
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics